Description
Picoplatin is an investigational drug being studied in clinical trials. It is a platinum-based compound, similar to other chemotherapy drugs used to treat cancer. In the context of colorectal cancer, it has been studied in early-phase trials (Phase 1) to evaluate its safety and how it is processed by the body when given orally compared to intravenously. The goal of these early trials is to determine the best way to administer the drug and to understand its effects before testing it in larger groups of patients or in combination with other treatments. It is important to note that Picoplatin is not currently an approved treatment for colorectal cancer.
Mechanism of Action
Picoplatin belongs to a class of drugs called platinum-based chemotherapy agents. These drugs work by damaging the DNA inside cancer cells, preventing them from dividing and growing. Picoplatin is designed to be administered either intravenously (through a vein) or orally (by mouth). Clinical trials are investigating how well the drug is absorbed and distributed in the body via these different routes, and how it compares to other platinum drugs.
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.